van den Dorpel, Mark M. P.
de Sá Marchi, Mauricio Felippi
Rahhab, Zouhair
Ooms, Joris F.
Adrichem, Rik
Verhemel, Sarah
Ren, Claire Ben
Nuis, Rutger-Jan
Daemen, Joost
Hirsch, Alexander
Van den Branden, Ben J. L.
Van Mieghem, Nicolas M.
Article History
Accepted: 12 July 2024
First Online: 16 September 2024
Conflict of interest
: N.M. Van Mieghem: Grants or contracts: Abbott, Boston Scientific, Biotronic, Edwards Lifesciences, Medtronic, Pulsecath BV, Abiomed, Daiichi Sankyo. Consulting Fees: Jenavalve, Daiichi Sankyo, Abbott, Boston Scientific, Medtronic. Payment or honoraria for lectures, presentations, speakers, manuscripts and educational events: Abiomed, Amgen, Jenavalve. J. Daemen: Grants or contracts: Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical. Consultancy and speaker fees: Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens and Medtronic. A. Hirsch: Grants, consultancy fees: GE Healthcare. Speaker fees: GE Healthcare and Bayer. He is also a member of the medical advisory board of Medis Medical Imaging Systems. Alexander Hirsch is an Editor for the Netherlands Heart Journal. M.M.P. van den Dorpel, M.F. de Sá Marchi, Z. Rahhab, J.F. Ooms, R. Adrichem, S. Verhemel, C.B. Ren, R.-J. Nuis and B.J.L. Van den Branden declare that they have no competing interests.